Edward Kliphuis

Partner, Board Member at Sofinnova Partners · Madrid, Spain

Invests in AI

Edward Kliphuis's investor profile lists AI alongside Healthcare & Biotech, at early-stage venture. The record holds 5 deals, among them l'école AI, Padlock Therapeutics and Latent Labs.

Email Investor

Email Investor

Credits to line up before an early-stage round

Edward Kliphuis backs companies at early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • l'école AI
  • Padlock Therapeutics
  • Latent Labs
  • Bioptimus
  • Excelsior Sciences

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech
Rounds
Early-stage venture
Profile
Angel investor
Deals on record
5
Based in
Madrid, Spain

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Edward Kliphuis invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Edward Kliphuis's investor profile, together with Healthcare & Biotech. The stages on record are early-stage venture.
Which companies has Edward Kliphuis backed?
The record lists 5 deals, including l'école AI, Padlock Therapeutics, Latent Labs, Bioptimus and Excelsior Sciences. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Edward Kliphuis?
For a company raising an early-stage round, AI Perks lists credits such as Weaviate (up to $100,000), Appwrite (up to $20,000), Beefree SDK (up to $10,000) and Alibaba Cloud (up to Up to $120,000 + 2B Model Studio tokens), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor